Invention Grant
- Patent Title: Norbornene modified peptides and their labelling with tetrazine compounds
-
Application No.: US14373292Application Date: 2013-01-21
-
Publication No.: US09968690B2Publication Date: 2018-05-15
- Inventor: Jason Chin , Alexander Deiters , Kathrin Lang
- Applicant: MEDICAL RESEARCH COUNCIL , NORTH CAROLINA STATE UNIVERSITY
- Applicant Address: GB Wiltshire US NC Raleigh
- Assignee: Medical Research Council,North Carolina State University
- Current Assignee: Medical Research Council,North Carolina State University
- Current Assignee Address: GB Wiltshire US NC Raleigh
- Agency: Bradley Arant Boult Cummings LLP
- Agent Thomas G. Peterson
- Priority: GB1201100.3 20120120
- International Application: PCT/GB2013/050121 WO 20130121
- International Announcement: WO2013/108044 WO 20130725
- Main IPC: C07K1/13
- IPC: C07K1/13 ; C07K7/64 ; A61K38/00 ; A61K49/00 ; C12P21/02 ; C07C271/34 ; C12N9/00 ; G01N33/58
Abstract:
The invention relates to a polypeptide comprising an amino acid having a norbornene group. Suitably said norbornene group is present as an amino acid residue of a norbornene lysine. The invention also relates to a method of producing a polypeptide comprising a norbornene group, said method comprising genetically incorporating an amino acid comprising a norbornene group into a polypeptide.
Public/Granted literature
- US20150005481A1 Norbornene Modified Peptides and Their Labelling With Tetrazine Compounds Public/Granted day:2015-01-01
Information query
